Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulfate vs Ipratropium Bromide in COPD Exacerbation
NCT01136421Phase 3Completed
- Sponsor
- Université de Monastir
- Start
- Jan 2005
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of magnesium sulfate in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Université de Monastir. Primary endpoints: Hospital admission rate, Endotracheal intubation rate and 1 more. Started Jan 2005; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01136421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01136421.